Quantcast
Connect with us

‘Fishing for white people’: Trump ordered plan from Sondland to ‘fast track’ immigration by Europeans into US

Published

on

Last year President Donald Trump ordered his U.S. Ambassador to the European Union, Gordon Sondland, to develop a plan that would “fast track” immigration by wealthy Europeans into the United States. It does not appear he ordered similar plans from any other ambassadors.

Sondland (photo, fourth from left) is now an embattled entity, having delivered damaging testimony confirming President Trump extorted a bribe from the President of Ukraine.

ADVERTISEMENT

But when he first took over as Ambassador to the E.U., Sondland “started talking to subordinates about a need for more skilled and wealthy European immigrants in the United States,” The Washington Post reports.

Believing Sondland’s orders were “racially motivated,” U.S. diplomats at the E.U. mission “were unsettled by the idea.”

One said, “the way this was going to come off was that the United States is fishing for white people, while reducing opportunities for needier people to immigrate.”

That diplomat was correct – not only in how the efforts would be perceived, but in their motivation.

That’s because President Trump, immediately upon Sondland being confirmed and taking over in Europe, tasked him with “developing a proposal to ‘fast track’ immigration from the E.U.,” and ordered Ambassador Sondland to consult with Trump’s top immigration adviser, Stephen Miller, and his son-in-law Jared Kushner.

ADVERTISEMENT

Miller, a known white nationalist, has been at the center of Trump’s successful efforts to block all refugees from entering the U.S. He was also behind Trump’s Muslim ban, and Trump’s policy of separating migrant children from their parents. He called the latter a “simple decision.”


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Peter Navarro warned Trump coronavirus could kill 500,000 Americans — back in January: NYT

Published

on

President Donald Trump was warned COVID-19 could be catastrophic, according to a bombshell new report published online by The New York Times on Monday evening.

"A top White House adviser starkly warned Trump administration officials in late January that the coronavirus crisis could cost the United States trillions of dollars and put millions of Americans at risk of illness or death," the newspaper reported.

"The warning, written in a memo by Peter Navarro, President Trump’s trade adviser, is the highest-level alert known to have circulated inside the West Wing as the administration was taking its first substantive steps to confront a crisis that had already consumed China’s leaders and would go on to upend life in Europe and the United States," The Times continued.

Continue Reading

Breaking Banner

Oil prices jump on hopes for output cut deal

Published

on

Oil prices rebounded Tuesday on fresh hopes an OPEC-led meeting this week will reach an agreement to reduce oversupply and shore up the market.

Prices have fallen sharply since expectations for a quick deal to cut output levels were dashed, but the rescheduling to Thursday of a meeting of major crude producers boosted sentiment.

US benchmark West Texas Intermediate was up 3.83 percent to $27.08 a barrel in Asian morning trade.

A barrel of Brent crude, the international benchmark, was trading 2.81 percent higher at $33.98.

Prices fell to 18-year lows last week as the market wallowed in oversupply arising from a price war between Saudi Arabia and Russia, which have ramped up production.

Continue Reading
 

Breaking Banner

Trump and his allies have financial ties to companies that manufacture untested drug he’s touting for COVID-19: report

Published

on

President Donald Trump's fixation with hydroxychloroquine, a drug used to treat malaria and lupus, as a potential treatment for the novel coronavirus has left many medical experts, including members of his own administration, frustrated. The drug comes with severe side effects ranging from nausea and hair loss to blindness and cardiac arrest; the hoarding of the drug to test it in COVID-19 patients has resulted in autoimmune patients being denied it, and the evidence that it even helps COVID-19 patients in the first place is anecdotal at best.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image